In 2023, there were ***** community hospitals (general acute care) in the United States. The largest portion of these hospitals were non-profit, while only around ** percent were for-profit. In recent years, there has been a decrease in the number of hospitals in the U.S. It is difficult to compare data from before 2017 due to methodology differences. However, the general trend is downwards, except for for-profit hospitals. There has been an increase in for-profit community hospitals in the last two decades.

This statistic depicts the percentage of hospitals in non-profit hospital systems in the United States from 1995 to 2016. According to the data, in 1995, 29 percent of hospitals were in non-profit systems. As of 2016, 51 percent of hospitals were in non-profit systems.

Forecast: Number of Beds in Not for Profit Privately Owned Hospitals in the US 2022 - 2026 Discover more data with ReportLinker!

As of February 2025, the Hospital Corporation of America, based in Nashville, Tennessee, was the largest health system in the United States, with a total of 222 hospitals. HCA Healthcare is also the largest U.S. health system when ranked by the number of beds and, as expected, by net patient revenue.Hospitals in the United StatesCurrently, there are approximately 6,120 hospitals in the United States. Looking over the past decades, this figure was constantly decreasing. For example, there were nearly 7,000 hospitals in 1980. There are some 5.3 million persons employed in U.S. hospitals in full-time. Contrary to the decrease in the number of hospitals, employment has been increasing steadily. According to the Bureau of Economic Analysis, U.S. hospitals generate a total gross output of around 1,075 billion U.S. dollars. The largest portion of U.S. hospitals are non-profit facilities. A smaller share includes private-owned for-profit hospitals. In most cases, these hospitals are part of hospital chains. For-profit hospitals developed especially in the 1990s, with the aim to gain profit for their shareholders. The Hospital Corporation of America, based in Nashville, Tennessee, is the U.S. for-profit hospital operator with the highest number of hospitals.

AdventHealth Orlando in Florida stands as the largest hospital in the United States, boasting an impressive 2,247 beds as of August 2024. This expansive facility exemplifies the scale of modern healthcare infrastructure, with Jackson Memorial Hospital, also in Florida, following as the second-largest. Evolving landscape of U.S. hospitals Despite the decline in the total number of hospitals since 1980, the healthcare sector continues to grow in other ways. U.S. hospitals now employ about 7.5 million workers and generate a gross output of around 1,161 billion U.S. dollars. The Hospital Corporation of America, based in Nashville, Tennessee, leads the pack as the largest health system in the country, operating 222 hospitals as of February 2025. This reflects a trend towards consolidation and the rise of for-profit hospital chains, which gained prominence in the 1990s. Specialization and emergency care While bed count is one measure of hospital size, institutions also distinguish themselves through specialization and emergency care capabilities. For instance, the University of California at Los Angeles Medical Center performed 22,287 organ transplants between January 1988 and March 2025, making it the leading transplant center in the nation. In terms of emergency care, Parkland Health and Hospital System in Dallas recorded the highest number of emergency department visits in 2022, with 226,178 patients seeking urgent care.

In 2022, there were 658 not-for-profit and 980 for-profit privately owned hospitals in France, while another 1,338 hospitals were publicly owned. This statistic shows the number of not-for-profit and for-profit privately owned hospitals in select countries worldwide in 2022.

Hospitals play a critical role in healthcare, offering specialized treatments and emergency services essential for public health, regardless of economic fluctuations or individuals' financial situations. Rising incomes and broader access to insurance have fueled demand for care in recent years, supporting hospitals' post-pandemic recovery initiated by federal policies and funding. The recovery for many hospitals was also promoted by mergers that lessened financial strains, especially in rural hospitals. This trend toward consolidation has resulted in fewer enterprises relative to establishments, enhancing hospitals' bargaining power regarding input costs and insurance reimbursements. With this improved position, hospitals are expected to see revenue climb at a CAGR of 2.0%, reaching $1.5 trillion by 2025, with a 3.2% increase in 2025 alone. Competition, economic conditions and regulatory changes will impact hospitals based on size and location. Smaller hospitals, particularly rural ones, may encounter more significant obstacles as the industry transitions from fee-based to value-based care. Independent hospitals face wage inflation, staffing shortages and drug supply costs. Although state and federal policies aim to support small rural hospitals in addressing hospital deserts, uncertainties linger over federal Medicare funding and Medicaid reimbursements, which account for nearly half of hospital care spending. Even so, increasing per capita disposable income and increasing the number of individuals with private insurance will boost revenues from private insurers and out-of-pocket payments for all hospitals, big and small. Hospitals will continue incorporating technological advancements in AI, telemedicine and wearables to enhance their services and reduce cost. These technologies aid hospital systems in strategically expanding outpatient services, mitigating the increasing competitive pressures from Ambulatory Surgery Centers (ASCs) and capitalizing on the increased needs of an aging adult population and shifts in healthcare delivery preferences. As the consolidation trend advances and technology adoption further leverages economies of scale, industry revenue is expected to strengthen at a CAGR of 2.4%, reaching $1.7 trillion by 2030, with steady profit over the period.

Specialty hospitals have seen positive growth despite Medicare and Medicaid funding fluctuations, swings in the number of insured individuals and changes in per capita disposable income. Supportive non-operating investment income and diverse payor sources have supported continued revenue growth. At the same time, substantial government funding during the pandemic and waivers permitting the implementation of telehealth allowed hospitals to weather short-term demand and cost shocks. Despite the variability in funding and demand shock, revenue grew at a CAGR of 2.1% to $64.7 billion in 2024, with revenue increasing by 1.2% in 2024 alone. Mergers and consolidation continue to be prevalent trends among specialty hospitals. Belonging to a larger hospital chain allows specialty hospitals to benefit from economies of scale and increased access to innovation. Consolidation empowers specialty hospitals in health insurance contract negotiations, resulting in favorable prices. Also, larger establishments can negotiate more favorable terms with suppliers of critical inputs, leading to decreased costs and increased profit. Technological innovation has been pivotal in enhancing care quality and reducing operational costs, and smaller independent specialty hospitals may face challenges in bringing this quality to the market. Considerable investment required to procure advanced technology at large general hospitals puts smaller, unaffiliated specialty hospitals at a disadvantage. The outlook for specialty hospitals remains positive. With the growth in Medicaid and Medicare funding continuing at previous levels and a healthy economy supporting increased private insurance coverage, revenue and profit will climb. While state-level Certificate of Need (CON) laws may influence geographic concentration and boost competition, the hospital chain organizational trend will strengthen negotiating capabilities with insurance companies and suppliers. Specialty hospitals are emphasizing outpatient services, including advanced same-day surgeries. This shift is driven by patient preference, cost-efficiency and innovations such as minimally invasive procedures. Advancements in telehealth and remote monitoring will let hospitals manage post-surgery care effectively, reducing inpatient admissions. Lastly, demographic and preference shifts (a growing adult population with a higher prevalence of chronic diseases and a younger demographic benefiting from state-of-the-art technology) will drive customers to seek healthcare services at specialty hospitals. Revenue is forecast to rally at a CAGR of 2.9% through 2029 to total $74.6 billion and profit increasing to 14.7%.

This statistic shows the results of a survey conducted in the United States in March 2017. U.S. adults were asked if they think that treatment in a for-profit hospital is better than in a non-profit hospital. In total, 11 percent of respondents that worked in the health care industry indicated that they believed for-profit hospitals had a much higher quality of care.

The graph displays the average hospital stay cost per inpatient day in the United States by hospital type from 1999 to 2022. The x-axis represents the years, ranging from 1999 to 2022, while the y-axis indicates the cost in dollars per inpatient day. The data is categorized into three types of hospitals: State/Local Government Hospitals, Non-Profit Hospitals, and For-Profit Hospitals.

In 1999, State/Local Government Hospitals had an average cost of $1,004.02 per inpatient day, which increased to $2,856.58 by 2022. Non-Profit Hospitals started with the highest costs at $1,139.49 in 1999 and rose to $3,166.58 in 2022, maintaining the highest costs among the three categories throughout the period. For-Profit Hospitals had the lowest starting cost at $999.03 in 1999 and reached $2,383.42 by 2022.

The data reveals that all hospital types experienced a consistent upward trend in costs over the 23-year period. Non-Profit Hospitals consistently had the highest costs, followed by State/Local Government Hospitals, and then For-Profit Hospitals. This upward trajectory highlights the increasing healthcare expenses in the United States across all types of hospitals.

Children's specialty hospitals represent less than 5% of all US hospitals but are vital to pediatric healthcare. Despite the disruptions caused by the pandemic, the industry experienced growth because of the inelastic demand for children's health services. While the pandemic raised operating costs, the adoption of telemedicine and government support helped mitigate significant declines in demand and revenue. The income and expense volatility in the recent period did not impact industry-wide revenue, which is expected to climb at a CAGR of 0.2% through 2024 to total $49.1 billion, increasing 1.0% in 2024. According to the American Academy of Pediatrics, children's hospitals often care for children than depend on Medicaid funds. Yet, hospitals receive only about two-thirds of the reimbursement for the total cost of care. Increased managed care, capitation payment agreements and state policy changes influencing Medicaid reimbursements can further impact payouts. Also, children's specialty hospitals face ongoing physician and nurse shortages, leading to a competitive environment that drives up wages. Despite these regulatory pressures and competition from general hospitals, children's specialty hospitals can rely on support from various industry associations, foundations and charities. Consolidation has become a common strategy to counter competitive forces and achieve economies of scale. However, advancements in telemedicine and innovations in wearables and medical devices could shift services away from specialty hospitals to other healthcare providers. Nonetheless, demand for services from children's specialty hospitals is expected to remain strong in response to the increasing prevalence of conditions such as asthma, obesity, diabetes and congenital anomalies among individuals under 18. By meeting this demand, industry revenue is predicted to strengthen at a CAGR of 3.0% through the end of 2029, reaching $56.9 billion, with profit expected to recover and surpass pre-pandemic levels.

This statistic shows the results of a survey conducted in the United States in March 2017, by ethnicity. U.S. adults were asked if they would prefer to go to a for-profit or a non-profit hospital for treatments. In total, 15 percent of Asian respondents preferred a for-profit hospital, compared to about 7 percent of Black or African American respondents.

As of 2024, the Hospital Corporation of America, based in Nashville, Tennessee, was the largest health system in the United States, with a total of 41,694 hospital beds. HCA Healthcare is also the largest U.S. health system when ranked by the number of hospitals and net patient revenue. Altogether, the largest 10 healthcare systems or integrated delivery networks (IDNs) cover 1,210 hospital and over 185,000 hospital beds. Most of these health systems are non-profit organizations.

The global Smart Triage Pack market is experiencing robust growth, driven by the increasing demand for efficient and effective emergency medical response systems. Technological advancements in telehealth, remote patient monitoring, and point-of-care diagnostics are significantly impacting the market. Hospitals, clinics, and non-profit organizations are increasingly adopting smart triage packs to streamline patient assessment and triage, leading to improved patient outcomes and reduced healthcare costs. The market is segmented by application (hospital, clinic, non-profit organizations, others) and type (with 20 smart category tags and 10 smart classification tags suggesting a diverse range of functionalities and features within the packs). Key players like QureMed, Bound Tree Medical, and Sands Canada are driving innovation and expanding their market presence through strategic partnerships and product development. The market's growth is further fueled by rising incidences of trauma and emergencies, coupled with a growing aging population requiring more frequent medical interventions. Regional variations exist, with North America and Europe currently holding significant market shares due to advanced healthcare infrastructure and high adoption rates of telehealth solutions. However, emerging economies in Asia-Pacific are expected to witness substantial growth in the coming years. Factors such as high initial investment costs and regulatory hurdles could potentially restrain market growth. The forecast period (2025-2033) indicates a continued upward trajectory for the smart triage pack market. We project a Compound Annual Growth Rate (CAGR) that accounts for both the current market dynamics and the expected expansion into new regions and applications. This growth will be largely driven by continuous technological improvements in the packs' capabilities and increasing integration with broader healthcare information systems, leading to more comprehensive and efficient patient care. While challenges remain, the overall outlook for the smart triage pack market remains positive, fueled by the ongoing need for faster, more accurate, and cost-effective emergency medical responses. The market is ripe for further innovation, focusing on expanding the functionalities of the packs, improving their portability, and reducing their overall cost to improve accessibility for a wider range of users.

An aging population, both in the US and globally, with growing healthcare expenditures, has driven demand for surgeries and necessary surgical instruments. As medical care resumed post-pandemic, growth was positive, but volatility lingered. Economic factors benefited growth but contributed to volatility. Growth in funding for Medicare and Medicaid supported healthcare expenditures, but declines in the number of individuals with private health insurance stressed growth and stifled pent-up demand. As a result, industry-wide revenue dropped at a CAGR of 0.1% over the past five years and is expected to total $45.2 billion in 2024, when revenue growth will be mild at an estimated 0.1%. Innovations in manufacturing and a shift in hospital costs redefine the competitive landscape. Additive manufacturing (3D printing), automation, computer-assisted design and new material resources will allow manufacturers to expand product lines, offer new services, enhance efficiency and reduce costs. These developments will give companies a competitive edge in the global markets and satisfy US consumers interested in reusability and reducing waste costs. Automation will reduce wage costs and human error, but 3D printing may spur entry, increasing competition and challenging profit. Looking ahead, manufacturers will encounter renewed growth. An uptick in the number of surgeries brought on by aging baby boomers seeking voluntary and needed surgeries and the obesity epidemic will spur a boost in product sales. Additionally, the number of individuals with private health insurance and increased government funding for Medicare and Medicaid will boost individuals' ability to pay and spur demand. Manufacturers' revenue will be influenced by the economic stability and import dynamics of critical partners like Mexico, Costa Rica and Ireland. These countries are crucial importers of interim products because of their robust manufacturing capabilities, skilled workforces and strategic advantages such as low labor costs and favorable trade agreements. With exports expected to climb and import growth to slow, industry revenue is expected to rally at a CAGR of 2.4% through 2029 to total $51.0 billion, with profit steady but not reaching pre-pandemic levels.

The United States freestanding emergency department (FED) market is experiencing robust growth, projected to reach $12.10 billion in 2025 and maintain a compound annual growth rate (CAGR) of 4.68% from 2025 to 2033. This expansion is driven by several key factors. The rising prevalence of chronic diseases necessitates quicker access to urgent care, fueling demand for convenient, readily available emergency services outside traditional hospital settings. The increasing uninsured and underinsured population also contributes to the growth, as FEDs offer a potentially more affordable alternative for non-life-threatening emergencies compared to hospital emergency rooms. Technological advancements, including improved telemedicine integration and advanced diagnostic imaging capabilities within FEDs, further enhance efficiency and attract patients. The market is segmented by ownership type (hospital-affiliated and independent) and service type (laboratory services, imaging services, emergency care, and other services). Major players like CHRISTUS Health, Ascension, and HCA Healthcare are strategically investing in expanding their FED networks, reflecting the market's lucrative potential. However, regulatory hurdles and reimbursement challenges present some restraints to market growth. The competitive landscape is characterized by a mix of large national chains and smaller regional providers. Independent FEDs often face challenges in negotiating favorable reimbursement rates with insurance providers, impacting their profitability. Hospital-affiliated FEDs, conversely, benefit from established networks and economies of scale. Future growth will likely be shaped by factors such as the continued evolution of healthcare reimbursement models, the increasing adoption of value-based care, and the ongoing expansion of telehealth services within the FED setting. The market’s expansion demonstrates a shift towards more accessible and convenient emergency care solutions, catering to the evolving needs of the US healthcare system and patient preferences. Continued innovation and strategic partnerships will be crucial for players to thrive in this dynamic market. Recent developments include: August 2024: Cadence's ER, an extension of Henderson Hospital, commenced operations its operations. This facility is poised to serve patients of all ages, especially as southern Nevada grapples with record-breaking heat and students head back to school. This marks the second freestanding emergency department under Henderson Hospital's umbrella, following the inaugural ER at Green Valley Ranch.August 2024: Ascension Sacred Heart unveiled its plans for a new freestanding ER in the Perdido Key area of Escambia County, located off Sorrento Road. The initiative aims to bolster access to emergency services, with construction slated for completion by the summer of 2025.. Key drivers for this market are: Growing Number of Consumer-driven Health Plans and Federal Funding, Rising Preference for Convenience Care. Potential restraints include: Growing Number of Consumer-driven Health Plans and Federal Funding, Rising Preference for Convenience Care. Notable trends are: Emergency Care and Other Services: Driving the FSED Market Growth.

Intravenous (IV) solution manufacturers have a critical role in healthcare delivery, supplying essential fluids like saline and dextrose used in virtually every care setting, from hospitals and surgical centers to outpatient infusion clinics. Historically, demand has remained stable and predictable, linked closely to procedure volumes and inpatient utilization. However, over the past five years, demand has accelerated because of a shift toward outpatient care, the rise of home infusions and growth in chronic disease management. The expansion of ambulatory surgery centers (ASCs) and non-hospital care sites has also created new, decentralized demand for IV fluids, increasing the number of delivery points. Despite being a commoditized product, IV solutions are volume-driven and critical to day-to-day patient care, which places pressure on manufacturers to deliver a consistent supply at a low price. The rising purchasing power of group purchasing organizations (GPOs) has intensified price competition among manufacturers, pushing prices lower and making it challenging for suppliers to invest in new capacity or product innovation. In all, revenue has risen at a CAGR of 0.2% to an estimated $3.4 billion over the past five years, including expected growth of 3.2% in 2025. In 2024, the industry’s vulnerability was exposed when Hurricane Helene severely disrupted Baxter’s North Cove facility in North Carolina, the single largest US producer, with this single facility accounting for roughly 60% of the national IV fluid supply. The flooding led to an immediate nationwide shortage, forcing hospitals to ration fluids and scramble for backup suppliers. The event highlighted the pitfalls of a highly concentrated industry where a handful of facilities produce nearly all the domestic supply. While competitors like B. Braun ramped up output and FEMA authorized emergency imports, the shortage underscored how disruptions have system-wide effects. The disruption at Baxter’s North Cove facility caused its market share to drop as hospitals and GPOs shifted orders to competitors like B. Braun and imports. This event pushed health systems and buyers to diversify their supplier base, weakening reliance on any single manufacturer and potentially prompting a long-term shift in market dynamics. IV solution manufacturing is expected to grow moderately, driven by outpatient expansion, aging demographics and increased chronic care treatment. However, growth will be uneven across settings: while hospitals remain the largest customers, infusion clinics and home care are driving new demand that requires more nimble packaging and distribution models. Manufacturers will be under pressure to modernize facilities, diversify geographic production and improve risk management capabilities. Long-term, demand will continue rising, but aggressive GPO pricing, high regulatory costs and the commoditized nature of the product will constrain profit. New competitors, including a Saudi-based IV production facility (announced in May 2025 in Trump’s Saudi-US economic partnership), could introduce headwinds too. Investments in automation and efficiency will be essential for manufacturers to remain competitive, control costs and maintain reliability. Revenue will expand moving forward, increasing at a CAGR of 2.3% to an estimated $3.9 billion over the next five years.

Institutional pharmacies have consolidated and generated solid revenue growth over the past five years. The aging population and rising obesity rates are leading to higher incidences of age-related health conditions that are filling hospitals and depleting healthcare providers' pharmaceutical supplies faster. Increased federal support has offset declining private insurance coverage brought by inflation and a shaky job market. Increased funding for Medicare and Medicaid has strengthened the financial health of institutional pharmacies' main clients as patients seek both essential and elective treatments. Major companies' dominance has allowed them to acquire competitors and boost profit. Revenue has been swelling at a CAGR of 1.2% to an estimated $24.8 billion over the five years through 2024, including an expected 0.9% uptick in 2024 alone. The contrast between brand-name and generic drugs significantly impacts institutional pharmacies. Brand-name medications are extremely expensive but especially lucrative for institutional pharmacies as healthcare providers have no choice but to purchase brand-name drugs to treat patients who may not respond well to generic alternatives. Brand-name pharmaceuticals' patents expire after some years, leading to the approval and release of more affordable generic substitutes. Still, the approval of new brand-name medications is expected to counterbalance revenue dips from patent expirations. Institutional pharmacies contend with little supplier power, so they can pass rising input costs downstream and protect profit. Demographics will continue to support institutional pharmacies' clients through the next five years. Adults aged 50 and older will form a larger part of the population, boosting demand for healthcare services and long-term care facilities. Institutional pharmacies will remain essential to keeping providers equipped to treat their patients' needs. Strong federal support with increased Medicare and Medicaid funding will create opportunities for new market entrants, though concentration is expected to continue rising. Major institutional pharmacies will leverage economies of scale to adapt to regulatory challenges, ensuring a resilient future with expanded offerings and specialized services. Revenue is set to climb at a CAGR of 2.2% to $27.7 billion through the end of 2029.

This statistic displays the number of investor-owned (for-profit) hospitals in the United States from 1975 to 2019. According to the data, in the year 2019, there were 1,233 investor-owned hospitals in the United States. The majority of the registered hospitals in the United States are considered to be community hospitals.

Orthopedic care has quickly become one of the largest healthcare spending categories in the US. An aging population's growing incidence of musculoskeletal conditions is behind higher spending, with rising rates of sports injuries also supporting the field's growth. In recent years, increasing access to health care and per capita disposable income has enabled more people to afford orthopedic products sold at retailers and access orthopedic medical procedures, boosting demand for orthopedic products. Yet, strengthening demand for orthopedic product production hasn't translated into meaningful revenue growth for manufacturers. Pandemic disruptions, supply chain snags, inflation and fluctuating currency exchange rates have made it challenging for domestic manufacturers to manage costs and navigate pricing pressures. Industry-wide revenue has swelled at a CAGR of 0.2% to an estimated $19.9 billion over the five years through 2024, including an expected downturn of 0.6% in 2024. Price inflation impacting the entire US manufacturing sector hasn't spared orthopedic products manufacturers. Production costs have risen since 2021 as manufacturers pay more for everything from metal to plastics and tech components. Higher prices for transportation have also been a key issue. Manufacturers have passed some of these inflated costs down to buyers, but not at a high enough rate to offset its impact on profitability. Contracts with downstream buyers have limited manufacturers' ability to fully pass on these costs, while some markets hard hit by the pandemic and inflation, like hospitals, are unwilling to accept price hikes. Spending on orthopedic procedures isn't likely to slow down in the coming years as a growing number of older adults require care for musculoskeletal conditions. At the same time, the strain of aging adults' needs on the health sector will require more innovative solutions, incentivizing manufacturers to introduce new, innovative orthopedic devices. While new product launches are a powerful way to drive growth, tech investments are cost- and time-intensive. Merger and acquisition activity may strengthen as manufacturers look to bypass these requirements while augmenting their tech portfolios. Revenue is set to climb at a CAGR of 1.4% to an estimated $$21.4 billion through the end of 2029.